pexelizumab

Related by string. * * pexelizumab trials *

Related by context. All words. (Click for frequent words.) 65 rolofylline 65 bicifadine 64 severe hypercholesterolemia 64 Asentar 64 oxymorphone ER 64 Fibrillex TM 64 elotuzumab 63 APEX AMI trial 63 Corlux 63 reslizumab 63 cinacalcet HCl 62 MAGE A3 ASCI 62 baminercept 62 ularitide 62 SILENOR 62 oral ridaforolimus 62 TOCOSOL Paclitaxel 62 cangrelor 62 PRIMO CABG2 62 nalbuphine ER 62 Bicifadine 62 OvaRex ® MAb 62 opioid induced bowel dysfunction 62 phase IIb clinical 62 Plicera 61 elagolix 61 hoFH 61 teduglutide 61 lintuzumab SGN 61 ZOLINZA 61 Amrubicin 61 Phenoptin 61 Sulonex 61 atherothrombotic events 61 budiodarone 61 alvimopan 61 clazosentan 61 MYDICAR 61 ocrelizumab 61 confirmatory clinical 61 tecarfarin 61 PROMACTA 61 Androxal TM 61 TKM ApoB 61 NATRECOR ® 61 axitinib 61 PRIMO CABG 60 lesinurad 60 valopicitabine 60 eculizumab 60 Rasilez Tekturna 60 lomitapide 60 Mipomersen 60 SinuNase TM 60 angiographic outcomes 60 cardiovascular hospitalizations 60 NV1FGF 60 RSD# oral 60 ruboxistaurin 60 Omigard 60 Viramidine 60 UPLYSO 60 teriflunomide 60 dexanabinol 60 Troxatyl 60 Canvaxin 60 PRADAXA 60 PEG PAL 60 pradefovir 60 vosaroxin 60 ruxolitinib 60 TELINTRA 60 recurrent VTE 60 dacetuzumab 60 tafamidis 60 JAK inhibitor 60 lumiliximab 60 cardiovascular hospitalization 60 pain palliation 60 Prestara 60 AEGR 60 aflibercept 60 custirsen 60 TELCYTA 60 Dextofisopam 60 CoFactor 60 LAF# 60 6R BH4 60 rhThrombin 60 Tocosol Paclitaxel 60 Egrifta 60 Zenvia ™ 60 DepoDur TM 60 IV APAP 60 apixaban 59 urocortin 2 59 Entereg R 59 TBC# 59 Triolex 59 Targeted Chemotherapy 59 phase IIa clinical 59 faropenem 59 TORISEL 59 Octreolin 59 xanthine oxidase inhibitor 59 Mylotarg 59 PRT# 59 phase III isavuconazole 59 KRN# 59 clopidogrel Plavix 59 dirucotide 59 Ixempra 59 dimebon 59 Stedivaze 59 Aflibercept 59 INTEGRILIN 59 terlipressin 59 Adentri 59 TYGACIL 59 celgosivir 59 ARCOXIA 59 Zemplar Capsules 59 Cimzia TM 59 ATACAND 59 glufosfamide 59 PFO migraine 59 rNAPc2 59 Panzem R NCD 59 Soliris TM eculizumab 59 morphometric vertebral fractures 59 confirmatory Phase III 59 AGGRASTAT ® 59 PEG INTRON 59 KIACTA ™ 59 AEG# 59 MEND CABG 59 Targretin 59 DES implantation 59 Navelbine ® 59 solanezumab 59 EFAPROXYN 59 ostarine 59 Zerenex 59 bazedoxifene 59 ezogabine 59 EDEMA3 59 fidaxomicin 59 brivaracetam 59 Xelox 59 SILENOR TM 59 PF # [002] 59 Tavocept 59 DU #b 59 adenosine injection 59 PEGylated interferon beta 1a 59 fondaparinux 58 R sorafenib tablets 58 Vorapaxar 58 MyVax personalized immunotherapy 58 supplemental biologics 58 nilotinib 58 Thalomid ® 58 SinuNase 58 RAPTIVA R 58 ImClone Erbitux 58 intravenous methylnaltrexone 58 TLK# 58 forodesine 58 EOquin TM 58 Nuvion 58 posaconazole 58 omecamtiv mecarbil 58 BRILINTA 58 darapladib 58 iniparib 58 IIIa inhibitor 58 Clonicel 58 eltrombopag 58 rindopepimut 58 febuxostat 58 CRMD# 58 romiplostim 58 REMICADE ® 58 ACTEMRA TM 58 CYCLOSET 58 Actimmune ® 58 NATRECOR R 58 docetaxel Taxotere ® 58 amrubicin 58 compound INCB# 58 AQ4N 58 tolevamer 58 NPS NPS Pharmaceuticals 58 lumiracoxib 58 sitaxsentan 58 enzastaurin 58 ONTAK 58 Pivotal Phase III 58 REMINYL ® 58 T Pred 58 catheter occlusion 58 antiplatelet agent 58 Phase IIIb clinical 58 cardiovascular morbidity 58 Gemzar ® 58 Anturol TM 58 Vascular Wrap 58 Rezular 58 Hyphanox 58 MERLIN TIMI 58 NYHA Class II 58 AERx iDMS 58 Solazed 58 ridaforolimus 58 tocilizumab 58 Peginterferon alfa 2b 58 ofatumumab 58 CIMZIA ™ 58 INCB# [003] 58 dextromethorphan quinidine 58 Noxafil 58 methylnaltrexone 58 RSR# 58 heterozygous FH 58 phase IIIb 58 venous thromboembolic events 58 Atrasentan 58 Chrysalin 58 Riquent 58 Panzem R 58 lintuzumab 58 AzaSite Plus 58 Bezielle 58 Allovectin 7 58 Sanctura XR 57 sunitinib Sutent 57 Dacogen injection 57 ancrod 57 glycoprotein IIb IIIa inhibitor 57 interferon gamma 1b 57 PREOS R 57 Vectibix panitumumab 57 retinal vein occlusion induced 57 schizophrenia CIAS 57 deforolimus 57 talactoferrin 57 R# #mg BID 57 Angiox ® 57 Cleviprex TM clevidipine 57 HoFH 57 SinuNase ™ 57 Entereg 57 GP IIb IIIa inhibitor 57 ABILIFY ® 57 parecoxib 57 E2F Decoy 57 EDEMA4 trial 57 efaproxiral 57 UVIDEM 57 MIST II 57 REVLIMID R 57 fluvastatin 57 Phase IIb clinical trials 57 FRAGMIN 57 diabetic neuropathic pain 57 Ereska 57 interferon ribavirin 57 mipomersen 57 sunitinib malate 57 Vicriviroc 57 phase IIb 57 INCB# [001] 57 Romiplostim 57 otelixizumab 57 SPRYCEL ® 57 metastatic castration resistant 57 levosimendan 57 Toremifene 57 phase IIb study 57 acyclovir Lauriad R 57 BRIM3 57 vernakalant iv 57 atacicept 57 DAPT 57 STRIDE PD 57 PEGINTRON TM 57 Torisel 57 arzoxifene 57 Ophena TM 57 fenofibric acid 57 ecallantide 57 IL# PE#QQR 57 Viprinex TM 57 Insegia 57 Retavase 57 TYZEKA 57 Aryplase 57 PROVENGE ® 57 phase IIa 57 Canvaxin TM 57 Ecallantide 57 Arcalyst 57 Tekturna HCT 57 huC# DM4 57 Phase 2b study 57 Fibrin Pad 57 abatacept 57 Jevtana 57 rThrombin 57 ELND# 57 OvaRex 57 PLK1 SNALP 57 LymphoStat B 57 Gattex 57 HuMax CD# 57 Anturol 57 GSK# [001] 57 Genasense ® oblimersen 57 Acapodene 57 gefitinib Iressa 57 Desmoteplase 57 phase IIb trial 57 cilengitide 57 PrevOnco 57 PRISTIQ 57 NSABP C 57 paliperidone ER 57 oral methylnaltrexone 57 Phase #b/#a clinical 57 Fondaparinux 57 lixivaptan 57 Zytiga 57 ximelagatran 57 MGCD# [001] 57 Starlix 56 oxaliplatin Eloxatin 56 mapatumumab 56 Phase IIa trial 56 efficacy endpoint 56 daclizumab 56 AVANDIA 56 Cloretazine R VNP#M 56 FOLOTYN 56 rt PA 56 BrachySil TM 56 vandetanib 56 Arixtra 56 Cerovive 56 iloperidone 56 HCV RESPOND 2 56 irbesartan 56 GATTEX 56 selective androgen receptor modulator 56 regadenoson 56 Phase IIa trials 56 ALTACE 56 Vascugel ® 56 ACUITY trial 56 ATryn ® 56 pseudobulbar affect PBA 56 REVLIMID ® 56 TASKi3 56 MAA submission 56 Esbriet ® 56 reinfarction 56 Zelapar 56 indiplon capsules 56 Proquin XR 56 CINTREDEKIN BESUDOTOX 56 FASLODEX 56 ATL# [002] 56 PREOS 56 pegloticase 56 pharmacokinetic equivalence 56 paclitaxel eluting stents 56 bifeprunox 56 ticagrelor 56 DIFICID 56 alvespimycin 56 RAPTIVA 56 ABSORB trial 56 Ocrelizumab 56 Onco TCS 56 ToGA 56 PLAVIX 56 Glufosfamide 56 ILUVIEN ® 56 registrational 56 Tarceva TM 56 Vitaxin 56 KNS # 56 Azixa 56 Myocet 56 Acetavance 56 canakinumab 56 LymphoStat B belimumab 56 betrixaban 56 Cancidas 56 radiation sensitizer 56 Xinlay 56 incyclinide 56 cannabinor 56 SILENOR ™ 56 ACE inhibitor ramipril 56 Cethrin 56 CIMZIA TM certolizumab pegol 56 Glypromate 56 Sanofi Aventis Taxotere 56 pegylated interferons 56 MyVax R 56 ARIKACE ™ 56 Phase III clinical 56 Pemetrexed 56 efficacy endpoints 56 apoptosis inducer 56 Zenvia Phase III 56 Specifid 56 MYDICAR ® 56 TRIOLEX 56 motavizumab 56 ZoMaxx 56 RhuDex ® 56 GOUT 56 TroVax 56 Cinryze TM 56 OMNARIS Nasal Spray 56 Azedra TM 56 vidofludimus 56 bardoxolone 56 MGd 56 BrachySil ™ 56 vismodegib 56 CIP TRAMADOL ER 56 Tekamlo 56 PRE SURGE 56 elinogrel 56 Proxinium TM 56 Firazyr 56 bivalirudin 56 riociguat 56 Phase IIB 56 Eltrombopag 56 symptomatic VTE 56 MNTX 56 Gralise 56 ZYFLO 56 OPAXIO TM 56 pomalidomide 56 ospemifene 56 senicapoc 56 Phase 1b trial 56 ELACYT 56 mRCC 56 Cloretazine 56 anidulafungin 56 TAXUS Stent 56 belinostat 56 MEND CABG II 56 olmesartan 56 Aptivus ® 56 APEX PD 56 PROTONIX 56 oxypurinol 56 RELIANT Trial 56 glucokinase activator 56 noninferiority 56 acetonide FA 56 HuLuc# 56 Frova ® 56 ORENCIA R 56 Ranexa 56 virus HCV protease inhibitor 56 EGS# 56 placebo controlled clinical 56 BENICAR HCT 56 fostamatinib 56 rosuvastatin #mg 56 NUEDEXTA 56 Fludara 56 dopamine partial agonist 56 BAY #-# 56 including eniluracil ADH 56 TAXUS Element Stent System 56 occlusion PAO 56 sorafenib Nexavar 56 Vidaza azacitidine 56 Aceon 56 FOLOTYN ® 56 binary restenosis 56 successfully commercialize Iluvien 56 Atacand 56 ATL# [001] 56 cilostazol 56 RSD# 56 cabazitaxel 56 oral prodrug 56 thromboembolic events 56 IV Busulfex 56 RoACTEMRA 56 lasofoxifene 56 Phase Ib clinical 55 Angiomax 55 antiarrhythmic drug 55 Pyridorin 55 Onrigin 55 EndoTAGTM 1 55 tanespimycin 55 CYPHER Stent 55 compound KOS 55 samalizumab 55 LEP ETU 55 pirfenidone 55 PLAVIX R 55 reduce serum phosphate 55 EndoTAG TM -1 55 Virulizin R 55 Ceplene 55 Eculizumab 55 OvaRex R 55 composite endpoint 55 selective modulator 55 bosutinib 55 velafermin 55 picoplatin 55 Xigris 55 neurologic progression 55 PSN# [002] 55 azacitidine 55 rALLy 55 rasagiline tablets 55 ApoB SNALP 55 Phase 2a trial 55 coxib 55 Neurodex 55 Promacta 55 eplerenone 55 refractory angina 55 hypoxia activated prodrug 55 KALBITOR 55 postoperative ileus 55 Ticagrelor 55 #D#C# 55 volociximab 55 investigational monoclonal antibody 55 Angiox R 55 pertuzumab 55 Fx #A 55 Tykerb lapatinib 55 Folotyn 55 Traficet EN 55 Cellegesic 55 INSPIRE Trial Phase III 55 Strativa 55 abiraterone acetate 55 orBec 55 RhuDex TM 55 Pimavanserin 55 EOquin 55 XIENCE V PROMUS Stent 55 VELCADE melphalan 55 Fablyn 55 lurasidone 55 ORENCIA ® 55 novel histone deacetylase 55 Gemzar gemcitabine 55 apaziquone 55 YONDELIS 55 PTK ZK 55 dalteparin 55 ANCHOR trial 55 Amigal 55 anti arrhythmic 55 angiographic restenosis 55 Trexima 55 certolizumab 55 Junovan 55 Sycrest 55 Aromasin 55 Genentech Roche 55 LEVADEX 55 Nexavar ® 55 trastuzumab DM1 T DM1 55 PSMA ADC 55 BROVANA 55 PhosLo 55 vinflunine 55 Dacogen decitabine 55 mycophenolate mofetil 55 ILLUMINATE 55 BRINAVESS 55 FACTIVE tablets 55 PHX# 55 zonisamide SR 55 esophageal candidiasis 55 edifoligide 55 briakinumab 55 naronapride 55 figitumumab 55 atrasentan 55 Elitek 55 evaluating Actimmune 55 balsalazide tablet 55 simvastatin ezetimibe 55 PLAVIX ® 55 IMA# 55 desvenlafaxine succinate 55 nebivolol 55 ACZ# 55 candesartan cilexetil 55 Zarnestra 55 ARC# [002] 55 valsartan 55 clodronate 55 Saforis 55 budesonide inhalation suspension 55 Onconase 55 sodium thiosulfate STS 55 HuMax EGFr 55 serum phosphorous 55 plus COPEGUS 55 treat chronic sinusitis 55 thrombotic events 55 sBLA 55 Ketotransdel 55 rFIXFc 55 Lixivaptan 55 EVIZON TM squalamine lactate 55 Kynapid 55 QNEXA 55 PDE4 inhibitor 55 Viprinex 55 MKC# MT 55 Dyloject TM 55 CORLUX 55 Targretin capsules 55 PEGylated anti 55 bone marrow reticulin deposition 55 temsirolimus 55 Valsartan 55 non splenectomized 55 induced macular edema 55 miconazole MBT 55 Orapred ODT 55 albiglutide 55 CIMZIA TM 55 Tezampanel 55 Factor VIIa 55 AVINZA 55 cintredekin besudotox 55 ExTRACT TIMI 55 AIM HIGH 55 NEVO ™ 55 XL# SAR# 55 plus dexamethasone 55 Entereg TM 55 muraglitazar 55 invasive aspergillosis 55 Kepivance 55 inhibitor RG# 55 phase Ib 55 LY# [003] 55 ELADUR 55 tirofiban 55 Unit Dose Budesonide 55 Zingo TM 55 ZEVALIN 55 Initiate Clinical Trial 55 peginesatide 55 recurrent GBM 55 malignant ascites 55 Vilazodone 55 indiplon 55 prospective multicenter randomized 55 alfimeprase 55 TRISENOX ® 55 Archexin 55 Lung Rx 55 darusentan 55 Rivaroxaban 55 sorafenib tablets 55 Civacir 55 levetiracetam Keppra 55 intranasal formulation 55 reteplase 55 Arzerra TM 55 drug figitumumab 55 Dasatinib 55 Ostarine 55 pivotal Phase III 55 Wellbutrin XL ® 55 edoxaban 55 REBETOL combination therapy 55 valdecoxib 55 Frova R 55 secondary efficacy endpoints 55 PEARL SC 55 sargramostim 55 AGGRASTAT R 54 SEPET TM 54 Levetiracetam 54 cancer neuroendocrine tumor 54 Phase 2b trial 54 Pirfenidone 54 randomized Phase IIb 54 recurrent malignant glioma 54 oxcarbazepine 54 metoprolol succinate 54 GP IIb IIIa inhibitors 54 Celebrex celecoxib 54 Cardio Vascu Grow 54 Shigamabs ® 54 Personalized Immunotherapy 54 ARIXTRA 54 injectable formulations 54 oral talactoferrin 54 Alfimeprase 54 rFVIIa 54 PFO closure 54 Lupuzor ™ 54 alogliptin 54 docetaxel chemotherapy 54 Phase 2b kidney transplant 54 PNP inhibitor 54 DASISION 54 aclidinium 54 RSD# iv 54 ponatinib 54 PROMUS 54 Instanyl 54 Rebif ® 54 PI3K/Akt pathway inhibitor 54 HspE7 54 OLEPTRO TM 54 Aclidinium 54 Dalbavancin 54 tolvaptan 54 Ethyol 54 eptifibatide 54 bortezomib Velcade 54 acute decompensated heart 54 Androxal 54 infusional 5-FU/LV 54 subgroup analyzes 54 Phase IIb clinical 54 budesonide foam 54 ALGRX 54 Velcade bortezomib 54 refractory chronic lymphocytic 54 Arranon 54 LibiGel ® 54 valtorcitabine 54 MOZOBIL 54 Dificid 54 alteplase 54 dyskinesia PD LID 54 INTEGRILIN ® 54 milnacipran 54 PEGylated Fab fragment 54 PROVIGIL 54 zalutumumab 54 tapentadol ER 54 Numax 54 NVA# 54 HBeAg negative patients 54 ALN VSP Phase 54 Ranolazine 54 ZEGERID Capsules 54 Ambrisentan 54 Celladon Corporation 54 MethyPatch 54 Plenaxis TM 54 HGS ETR1 54 trospium 54 Aegerion 54 ICA # 54 cardiac repolarization 54 COPEGUS 54 antibody MAb 54 nonfatal MI 54 R#/MEM # 54 SAPHRIS 54 regorafenib 54 2 methoxyestradiol 54 rufinamide 54 REOPRO 54 SANVAR 54 PROVENGE 54 clevidipine 54 palonosetron 54 recurrent herpes labialis 54 ACAPODENE 54 lexidronam injection 54 Gabapentin GR 54 StaphVAX 54 Aurexis 54 Avanafil 54 Vernakalant 54 DEB# 54 active comparator 54 metastatic malignant 54 tesmilifene 54 imatinib therapy 54 FACTIVE R gemifloxacin 54 AVONEX ® 54 Integrilin 54 Azedra 54 Maximum Tolerated Dose 54 enoximone 54 LEVADEX ™ 54 octreotide implant 54 HZT 54 coadministration 54 satraplatin 54 Argatroban 54 Phase Ib 54 HGS ETR2 54 CytoFab 54 AGILECT R 54 MAXY alpha 54 dabigatran etexilate 54 LymphoStat B TM 54 MEK inhibitor 54 NeuroSTAT ® 54 CytoFabTM 54 Genentech Rituxan 54 ITAX 54 metastatic hormone refractory 54 primary hypercholesterolemia 54 FOLFIRI 54 Xenazine ® 54 TRISENOX 54 AZILECT R 54 oral Xeloda 54 randomized discontinuation trial 54 Completes Patient Enrollment 54 rivaroxaban 54 prasugrel Effient 54 Doxil ® 54 aliskiren 54 Icatibant 54 #.#/#.# mmHg [001] 54 Elagolix 54 FDA defined valvulopathy 54 Golimumab 54 LEVAQUIN 54 dirucotide MBP# 54 Phase Ib study 54 SNS# T 54 noninferior 54 Roche Actemra 54 linaclotide 54 AMEVIVE 54 rALLy trial 54 LEUKINE 54 Prosaptide 54 HGS# 54 PegIntron 54 panitumumab 54 PXD# 54 POSIDUR TM 54 decitabine 54 Itopride 54 aplindore 54 dosing cohort 54 Acute Radiation Syndrome ARS 54 FROVA 54 EP #R 54 Amoxicillin PULSYS Phase III 54 registrational trial 54 vicriviroc 54 KRAS mutations occur 54 Sprycel dasatinib 54 TOCOSOL Camptothecin 54 atorvastatin Lipitor 54 plus prednisone 54 Tovaxin 54 Vicinium TM 54 ticagrelor Brilinta 54 oxycodone CR 54 nicardipine 54 Eloxatin ® 54 Temsirolimus 54 Bifeprunox 54 Pfizer Sutent 54 MBP# [001] 54 Mimpara 54 Folfox 54 Virulizin ® 54 Val HeFT 54 Fentanyl TAIFUN R 54 divalproex sodium 54 OPAXIO 54 Cardene 54 ISIS # 54 molecular imaging radiopharmaceutical 54 generation purine nucleoside 54 CANCIDAS 54 BARACLUDE R 54 goserelin 54 YERVOY 54 everolimus eluting stents 54 cladribine tablets 54 dose cohorts 54 adjuvant colon cancer 54 aprepitant 54 Vivitrex 54 oral rivaroxaban 54 Angiox 54 apremilast 54 Onalta ™ 54 Nebido 54 PENTASA 54 Paraplatin 54 retigabine 54 PDE# inhibitors 53 PS# [001] 53 varespladib 53 ARCALYST 53 metastatic HRPC 53 Zenvia 53 IFN alfa 53 Exalgo 53 Aloxi injection 53 GALNS 53 visilizumab 53 Phase IIb III 53 anticlotting drugs 53 TAXUS Liberte Long 53 novel oral anticoagulant 53 ranolazine 53 antiplatelet drugs 53 Losartan 53 Glybera 53 mucosal healing 53 UCB Keppra 53 Phenserine 53 MBP# dirucotide 53 corticosteroid dexamethasone 53 PRX # 53 oral anticoagulant 53 Dose Ranging Study 53 Epratuzumab 53 carotid endarterectomy CEA 53 Soliris eculizumab 53 IMiDs 53 zileuton 53 icatibant 53 ambrisentan 53 mertansine 53 Ventavis ® 53 ENTEREG 53 STELARA TM 53 vernakalant 53 Panitumumab 53 SPARLON 53 CYT# potent vascular disrupting 53 salmeterol fluticasone 53 Achieves Primary Endpoint 53 MAXY G# 53 recurrent glioblastoma multiforme 53 Marqibo 53 Tasimelteon 53 Welchol 53 INVEGA SUSTENNA 53 Aggrastat 53 cediranib 53 Zyflo 53 Resten NG 53 maximally tolerated dose 53 sumatriptan naproxen sodium 53 relapsed refractory multiple myeloma 53 RITUXAN 53 ZYFLO CR 53 AZD# 53 MyVax 53 pioglitazone Actos 53 colesevelam HCl 53 nesiritide 53 TNF inhibitor 53 rhIGF-I/rhIGFBP-3 53 Cotavance 53 HCD# [002] 53 KYNAPID 53 PEG Interferon lambda 53 ACCORD Lipid 53 Cangrelor 53 pralatrexate 53 Ozarelix 53 THALOMID 53 GGF2 53 COMFORT II 53 ThermoDox R 53 VISICOL R 53 MEVACOR 53 thienopyridines 53 pegylated liposomal doxorubicin 53 ONTARGET 53 Pennsaid R 53 ULORIC

Back to home page